• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

虚拟筛选与实体筛选的整合

Integration of virtual and physical screening.

作者信息

Fara Dan C, Oprea Tudor I, Prossnitz Eric R, Bologa Cristian G, Edwards Bruce S, Sklar Larry A

机构信息

Department of Biochemistry and Molecular Biology, Division of Biocomputing, University of New Mexico, Health Sciences Center, Albuquerque, NM 87131, USA.

Department of Cell Biology and Physiology, University of New Mexico, Health Sciences Center, Albuquerque, NM 87131, USA.

出版信息

Drug Discov Today Technol. 2006 Winter;3(4):377-385. doi: 10.1016/j.ddtec.2006.11.003. Epub 2006 Dec 14.

DOI:10.1016/j.ddtec.2006.11.003
PMID:38620118
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7105924/
Abstract

High-throughput screening (HTS) represents the dominant technique for the identification of new lead compounds in current drug discovery. It consists of physical screening (PS) of large libraries of chemicals against one or more specific biological targets. Virtual screening (VS) is a strategy for evaluation of chemical libraries for a given target, and can be integrated to focus the PS process. The present work addresses the integration of both PS and VS, respectively.

摘要

高通量筛选(HTS)是当前药物研发中鉴定新先导化合物的主要技术。它包括针对一个或多个特定生物靶点对大量化学物质库进行物理筛选(PS)。虚拟筛选(VS)是针对给定靶点评估化学物质库的一种策略,可用于聚焦物理筛选过程。本研究分别探讨了物理筛选和虚拟筛选的整合。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a592/7105924/6ab80f59876f/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a592/7105924/9d7a506601ea/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a592/7105924/925cf037e9da/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a592/7105924/6ab80f59876f/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a592/7105924/9d7a506601ea/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a592/7105924/925cf037e9da/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a592/7105924/6ab80f59876f/gr3.jpg

相似文献

1
Integration of virtual and physical screening.虚拟筛选与实体筛选的整合
Drug Discov Today Technol. 2006 Winter;3(4):377-385. doi: 10.1016/j.ddtec.2006.11.003. Epub 2006 Dec 14.
2
Novel trends in high-throughput screening.高通量筛选的新趋势。
Curr Opin Pharmacol. 2009 Oct;9(5):580-8. doi: 10.1016/j.coph.2009.08.004. Epub 2009 Sep 21.
3
Development and Testing of Druglike Screening Libraries.药物筛选库的开发与测试。
J Chem Inf Model. 2019 Jan 28;59(1):53-65. doi: 10.1021/acs.jcim.8b00537. Epub 2019 Jan 3.
4
Maximizing the integration of virtual and experimental screening in hit discovery.最大化虚拟筛选和实验筛选在命中发现中的整合。
Expert Opin Drug Discov. 2022 Jun;17(6):629-640. doi: 10.1080/17460441.2022.2085685. Epub 2022 Jun 14.
5
Virtual screening for the discovery of bioactive natural products.用于发现生物活性天然产物的虚拟筛选
Prog Drug Res. 2008;65:211, 213-49. doi: 10.1007/978-3-7643-8117-2_6.
6
A Multimodal Data Analysis Approach for Targeted Drug Discovery Involving Topological Data Analysis (TDA).一种涉及拓扑数据分析(TDA)的靶向药物发现多模态数据分析方法。
Adv Exp Med Biol. 2016;899:253-68. doi: 10.1007/978-3-319-26666-4_15.
7
High throughput virtual screening (HTVS) of peptide library: Technological advancement in ligand discovery.高通量虚拟筛选(HTVS)肽库:配体发现的技术进展。
Eur J Med Chem. 2022 Dec 5;243:114766. doi: 10.1016/j.ejmech.2022.114766. Epub 2022 Sep 13.
8
Augmenting Hit Identification by Virtual Screening Techniques in Small Molecule Drug Discovery.小分子药物发现中的虚拟筛选技术增强命中鉴定。
J Chem Inf Model. 2020 Sep 28;60(9):4144-4152. doi: 10.1021/acs.jcim.0c00113. Epub 2020 May 1.
9
The holistic integration of virtual screening in drug discovery.虚拟筛选在药物发现中的整体整合。
Drug Discov Today. 2013 Apr;18(7-8):358-64. doi: 10.1016/j.drudis.2013.01.007. Epub 2013 Jan 20.
10
Virtual high throughput screening (vHTS)--a perspective.虚拟高通量筛选(vHTS)——一种观点
Bioinformation. 2008;3(1):14-7. doi: 10.6026/97320630003014. Epub 2008 Sep 8.

引用本文的文献

1
Navigating chemical space: multi-level Bayesian optimization with hierarchical coarse-graining.探索化学空间:基于分层粗粒化的多级贝叶斯优化
Chem Sci. 2025 Jul 30. doi: 10.1039/d5sc03855c.
2
The evolution and application of RNA-focused small molecule libraries.以RNA为重点的小分子文库的演变与应用。
RSC Chem Biol. 2025 Feb 13;6(4):510-527. doi: 10.1039/d4cb00272e. eCollection 2025 Apr 2.
3
Advances in virtual screening.虚拟筛选的进展。

本文引用的文献

1
Inhibitor discovery targeting the intermediate structure of beta-amyloid peptide on the conformational transition pathway: implications in the aggregation mechanism of beta-amyloid peptide.靶向β-淀粉样肽构象转变途径中间结构的抑制剂发现:对β-淀粉样肽聚集机制的启示
Biochemistry. 2006 Sep 12;45(36):10963-72. doi: 10.1021/bi060955f.
2
Structure-based drug design and structural biology study of novel nonpeptide inhibitors of severe acute respiratory syndrome coronavirus main protease.基于结构的严重急性呼吸综合征冠状病毒主要蛋白酶新型非肽抑制剂的药物设计与结构生物学研究
J Med Chem. 2006 Aug 24;49(17):5154-61. doi: 10.1021/jm060207o.
3
Drug Discov Today Technol. 2006 Winter;3(4):405-411. doi: 10.1016/j.ddtec.2006.12.002. Epub 2007 Jan 12.
4
In silico DFT study, molecular docking, and ADMET predictions of cytidine analogs with antimicrobial and anticancer properties.具有抗菌和抗癌特性的胞苷类似物的计算机辅助密度泛函理论(DFT)研究、分子对接及药物代谢动力学/药物毒性(ADMET)预测
In Silico Pharmacol. 2021 Jul 6;9(1):42. doi: 10.1007/s40203-021-00102-0. eCollection 2021.
5
The perceptions of natural compounds against dipeptidyl peptidase 4 in diabetes: from to .天然化合物对糖尿病中双肽基肽酶4的作用:从……到……
Ther Adv Chronic Dis. 2019 Sep 19;10:2040622319875305. doi: 10.1177/2040622319875305. eCollection 2019.
6
High-throughput virtual screening with e-pharmacophore and molecular simulations study in the designing of pancreatic lipase inhibitors.基于电子药效团的高通量虚拟筛选及分子模拟研究在胰脂肪酶抑制剂设计中的应用
Drug Des Devel Ther. 2015 Aug 6;9:4397-412. doi: 10.2147/DDDT.S84052. eCollection 2015.
7
QSAR modeling: where have you been? Where are you going to?定量构效关系模型:你从何处来?你将往何处去?
J Med Chem. 2014 Jun 26;57(12):4977-5010. doi: 10.1021/jm4004285. Epub 2014 Jan 6.
8
Drug Repurposing from an Academic Perspective.从学术角度看药物重新利用
Drug Discov Today Ther Strateg. 2011 Winter;8(3-4):61-69. doi: 10.1016/j.ddstr.2011.10.002.
9
Transporter-mediated Efflux Influences CNS Side Effects: ABCB1, from Antitarget to Target.转运体介导的外排影响中枢神经系统副作用:ABCB1,从非靶点到靶点。
Mol Inform. 2010 Jan 12;29(1-2):16-26. doi: 10.1002/minf.200900075.
10
Adaptation of high-throughput screening in drug discovery-toxicological screening tests.高通量筛选在药物发现中的应用——毒理学筛选试验。
Int J Mol Sci. 2012;13(1):427-52. doi: 10.3390/ijms13010427. Epub 2011 Dec 29.
Fatty acid amide hydrolase inhibitors from virtual screening of the endocannabinoid system.
通过对内源性大麻素系统进行虚拟筛选得到的脂肪酸酰胺水解酶抑制剂
J Med Chem. 2006 Jul 27;49(15):4650-6. doi: 10.1021/jm060394q.
4
Virtual ligand screening: strategies, perspectives and limitations.虚拟配体筛选:策略、前景与局限性
Drug Discov Today. 2006 Jul;11(13-14):580-94. doi: 10.1016/j.drudis.2006.05.012.
5
Discovery of a nanomolar inhibitor of the human murine double minute 2 (MDM2)-p53 interaction through an integrated, virtual database screening strategy.通过综合虚拟数据库筛选策略发现一种纳摩尔级别的人鼠双微体2(MDM2)-p53相互作用抑制剂。
J Med Chem. 2006 Jun 29;49(13):3759-62. doi: 10.1021/jm060023+.
6
The discovery of new 11beta-hydroxysteroid dehydrogenase type 1 inhibitors by common feature pharmacophore modeling and virtual screening.通过共同特征药效团建模和虚拟筛选发现新型11β-羟基类固醇脱氢酶1型抑制剂
J Med Chem. 2006 Jun 15;49(12):3454-66. doi: 10.1021/jm0600794.
7
Synthetic curcuminoids modulate the arachidonic acid metabolism of human platelet 12-lipoxygenase and reduce sprout formation of human endothelial cells.合成姜黄素类化合物调节人血小板12-脂氧合酶的花生四烯酸代谢并减少人内皮细胞的芽形成。
Mol Cancer Ther. 2006 May;5(5):1371-82. doi: 10.1158/1535-7163.MCT-06-0021.
8
Consensus scoring for protein-ligand interactions.蛋白质-配体相互作用的共识评分
Drug Discov Today. 2006 May;11(9-10):421-8. doi: 10.1016/j.drudis.2006.03.009.
9
Structure-based pharmacophore design and virtual screening for novel angiotensin converting enzyme 2 inhibitors.基于结构的新型血管紧张素转换酶2抑制剂的药效团设计与虚拟筛选
J Chem Inf Model. 2006 Mar-Apr;46(2):708-16. doi: 10.1021/ci0503614.
10
Virtual and biomolecular screening converge on a selective agonist for GPR30.虚拟筛选和生物分子筛选共同找到了一种GPR30的选择性激动剂。
Nat Chem Biol. 2006 Apr;2(4):207-12. doi: 10.1038/nchembio775. Epub 2006 Mar 5.